Literature DB >> 26335813

The role of lysosomal proteinases and estradiol in neurodegeneration induced by beta-amyloid.

N L Rendakov1, L A Lysenko, Yu V Lyupina, N P Sharova, N B Sel'verova, N N Nemova.   

Abstract

Activation of lysosomal degradation process in nervous tissue may be neuroprotective. One of the factors that may influence on expression of lysosomal proteinases is the sex hormone, estradiol (E2). In this regard the expression of lysosomal proteinases after intracerebral injection of beta-amyloid peptide (Aβ) was investigated as well as the neuroprotective effect of E2 in Aβ-induced neurodegeneration. Intracerebral injection of Aβ was shown to cause the significant increase in expression of cathepsin D in rat hippocampus and cerebral cortex. On the background of Aβ intoxication, E2 treatment resulted in further increase in cathepsin D gene expression in hippocampus region and in its lowering to the control level in cerebral cortex. It was demonstrated for the first time that neuroprotective effect of E2 may be mediated by cathepsin D up-regulation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26335813     DOI: 10.1134/S160767291504002X

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.788


  14 in total

1.  Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model.

Authors:  Xu Yue; Melissa Lu; Techie Lancaster; Phillip Cao; Shin-Ichiro Honda; Matthias Staufenbiel; Nobuhiro Harada; Zhenyu Zhong; Yong Shen; Rena Li
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

2.  Alteration of cathepsins and actin genes expression in rat brain during ageing.

Authors:  N L Rendakov; L V Topchieva; I A Vinogradova; N N Nemova
Journal:  Dokl Biol Sci       Date:  2011-03-05

3.  Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy.

Authors:  Sooyeon Lee; Yutaka Sato; Ralph A Nixon
Journal:  J Neurosci       Date:  2011-05-25       Impact factor: 6.167

4.  Estrogens and Alzheimer disease risk: is there a window of opportunity?

Authors:  Victor W Henderson; Walter A Rocca
Journal:  Neurology       Date:  2012-10-24       Impact factor: 9.910

5.  Cathepsin B degrades amyloid-β in mice expressing wild-type human amyloid precursor protein.

Authors:  Chao Wang; Binggui Sun; Yungui Zhou; Anders Grubb; Li Gan
Journal:  J Biol Chem       Date:  2012-09-28       Impact factor: 5.157

Review 6.  Interactive effects of age and estrogen on cortical neurons: implications for cognitive aging.

Authors:  M E Bailey; A C J Wang; J Hao; W G M Janssen; Y Hara; D Dumitriu; P R Hof; J H Morrison
Journal:  Neuroscience       Date:  2011-06-02       Impact factor: 3.590

Review 7.  Autophagy failure in Alzheimer's disease--locating the primary defect.

Authors:  Ralph A Nixon; Dun-Sheng Yang
Journal:  Neurobiol Dis       Date:  2011-02-03       Impact factor: 5.996

8.  Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways.

Authors:  Emily R Rosario; Jenna Carroll; Christian J Pike
Journal:  Brain Res       Date:  2010-08-31       Impact factor: 3.252

9.  Selective estrogen receptor modulators differentially regulate Alzheimer-like changes in female 3xTg-AD mice.

Authors:  Jenna C Carroll; Christian J Pike
Journal:  Endocrinology       Date:  2008-02-14       Impact factor: 4.736

10.  Cathepsin D gene of human MCF7 cells contains estrogen-responsive sequences in its 5' proximal flanking region.

Authors:  V Cavailles; P Augereau; H Rochefort
Journal:  Biochem Biophys Res Commun       Date:  1991-01-31       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.